Form 4: Astronics Corp. Executive James S. Kramer Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 5 March 2024 4:25 PM

James S. Kramer, VP of Luminescent Systems, Inc., reports acquisition and disposal of Astronics Corp. stock and stock options related to bonus plans and 401(k) contributions.

Summary

James S. Kramer, VP of Luminescent Systems, Inc., filed a Form 4 detailing changes in his beneficial ownership of Astronics Corp. securities.
The transactions include the acquisition of common stock as part of the 2023 bonus plan payout, both for Q4 and the full year, paid in shares instead of cash.
Shares were also withheld to cover applicable withholding taxes upon the grant of the stock bonus award.
The report also reflects the issuer's contribution to Kramer's account in the issuer stock fund included in the issuer's 401(k) plan.
Kramer also holds various stock options and restricted stock units (RSUs) with different vesting schedules and performance-based vesting conditions tied to Astronics Corp.'s average annual adjusted EBITDA.
The vesting of RSUs depends on Astronics Corp.'s average annual adjusted EBITDA for various periods, with the number of units vesting ranging from 50% to 150% of the target number based on actual performance.

Sentiment

Score: 6

Explanation: The document is neutral, reporting standard executive compensation transactions. The vesting of RSUs based on EBITDA performance is a positive incentive, but also introduces some uncertainty.

Positives

The acquisition of shares as part of the bonus plan payout indicates confidence in the company's future performance.
The company's contribution to the 401(k) plan is a positive benefit for employees.
The vesting of RSUs being tied to EBITDA performance incentivizes management to improve profitability.

Negatives

Shares were withheld to cover withholding taxes, reducing the total number of shares received.
The vesting of RSUs is dependent on the company's EBITDA performance, which introduces uncertainty.

Risks

The value of the stock and options is subject to market fluctuations.
The vesting of RSUs is contingent on the company achieving certain EBITDA targets, which may not be met.
Changes in tax laws could impact the value of the stock and options.

Future Outlook

The vesting of restricted stock units is tied to the company's future EBITDA performance, suggesting that management is incentivized to improve profitability.

Industry Context

Executive stock ownership and compensation are common practices in publicly traded companies to align management's interests with those of shareholders. The use of performance-based vesting for RSUs is also a common practice to incentivize specific financial goals.

Comparison to Industry Standards

Stock option grants and RSU awards are standard components of executive compensation packages in the aerospace and defense industry, which includes companies like Boeing, Lockheed Martin, and Raytheon Technologies.
Performance-based vesting of RSUs, tied to metrics like EBITDA or revenue growth, is also a common practice among these companies to align executive compensation with company performance.
The vesting percentages of 75%-115% or 50%-150% of target units based on performance are within the typical range observed in similar companies.

Stakeholder Impact

Shareholders may view the stock acquisitions as a positive sign of management's confidence in the company.
Employees participating in the 401(k) plan benefit from the company's contributions to their accounts.
The performance-based vesting of RSUs aligns management's interests with those of shareholders, potentially leading to improved company performance.

Key Dates

Date	Description
12/11/2015	Grant date for some stock options with an exercise price of $30.83 and an expiration date of 12/11/2024
12/03/2016	Grant date for some stock options with an exercise price of $27.72 and an expiration date of 12/03/2025
12/14/2017	Grant date for some stock options with an exercise price of $31.76 and an expiration date of 12/14/2026
12/12/2018	Grant date for some stock options with an exercise price of $35.61 and an expiration date of 12/12/2027
12/13/2019	Grant date for some stock options with an exercise price of $31.57 and an expiration date of 12/13/2028
12/09/2020	Grant date for some stock options with an exercise price of $30.04 and an expiration date of 12/09/2029
January 1, 2021December 31, 2023	Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units.
01/22/2022	Grant date for some stock options with an exercise price of $14.45 and an expiration date of 01/22/2031
January1, 2022December 31, 2024	Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units.
12/09/2022	Grant date for some stock options with an exercise price of $11.13 and an expiration date of 12/09/2031
January 1, 2023December 31, 2025	Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units.
12/16/2023	Grant date for some stock options with an exercise price of $9.74 and an expiration date of 12/16/2032
03/01/2024	Date of transactions involving common stock acquisition and disposal.
January 1, 2024December 31, 2026	Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units.
03/04/2024	Date of issuer's contribution to the reporting person's account in the issuer stock fund included in the issuer's 401(k) plan.
12/07/2024	Grant date for some stock options with an exercise price of $15.15 and an expiration date of 12/07/2033
03/05/2024	Date of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.